High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,420
-480 (-3.02%)
At close: Mar 19, 2026
Market Cap205.65B +30.4%
Revenue (ttm)70.18B -9.5%
Net Income11.48B -16.3%
EPSn/a
Shares Out10.63M
PE Ratio17.92
Forward PEn/a
Dividend150.00 (0.78%)
Ex-Dividend DateDec 29, 2025
Volume42,699
Average Volume81,470
Open16,280
Previous Close15,900
Day's Range15,050 - 16,280
52-Week Range10,700 - 17,800
Beta0.61
RSI71.78
Earnings DateApr 1, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2025, High Tech Pharm's revenue was 70.18 billion, a decrease of -9.46% compared to the previous year's 77.51 billion. Earnings were 11.48 billion, a decrease of -16.30%.

Financial Statements